Cargando…

Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in India

BACKGROUND: Molecular tests in solid tumours for targeted therapies call for the need to ensure precision testing. To accomplish this participation in the External Quality Assessment Program (EQAS) is required. This evaluates the consistency of diagnostic testing procedures and offers guidance for i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shetty, Omshree, Shet, Tanuja, Iyer, Ramya, Gogte, Prachi, Gurav, Mamta, Joshi, Pradnya, Karnik, Nupur, Pai, Trupti, Epari, Sridhar, Desai, Sangeeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498956/ https://www.ncbi.nlm.nih.gov/pubmed/36137153 http://dx.doi.org/10.1371/journal.pone.0274089

Ejemplares similares

COVID 19 pandemic testing time – Crisis or opportunity in disguise for India?
por: Shetty, Omshree, et al.
Publicado: (2021)

Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience
por: Pai, Trupti, et al.
Publicado: (2017)

MBRS-61. MOLECULAR SUB-GROUPING OF PEDIATRIC MEDULLOBLASTOMA: CORRELATION WITH CLINICAL AND HISTOLOGICAL FEATURES, A SINGLE INSTITUTIONAL STUDY
por: Deshpande, Gauri, et al.
Publicado: (2020)

Interpretation of EQA results and EQA-based trouble shooting
por: Kristensen, Gunn Berit Berge, et al.
Publicado: (2017)

Pilomatrix Carcinoma Masquerading as Breast Carcinoma
por: Pai, Trupti, et al.
Publicado: (2017)

Demystifying EQA statistics and reports
por: Coucke, Wim, et al.
Publicado: (2017)

External Quality Assessment (EQA) for Molecular Diagnostics of Zika Virus: Experiences from an International EQA Programme, 2016–2018
por: Donoso Mantke, Oliver, et al.
Publicado: (2018)

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer
por: Behel, Vichitra, et al.
Publicado: (2022)

Inter-Laboratory Comparisons and EQA in the Mediterranean Area
por: Haliassos, Alexander
Publicado: (2018)

The challenge of producing an EQA for the COVID-19 pandemic
por: Badrick, Tony, et al.
Publicado: (2020)

The role of EQA in harmonization in laboratory medicine – a global effort
por: Jones, Graham R.D.
Publicado: (2017)

Coamplification with Colocalization of the Human Epidermal Growth Factor Receptor 2 and Centromeric-17 Signals on Fluorescence In Situ Hybridization in Invasive Breast Carcinoma: An Exceedingly Rare Finding
por: Pai, T, et al.
Publicado: (2016)

Estimating the parasitaemia of Plasmodium falciparum: experience from a national EQA scheme
por: Manser, Monika, et al.
Publicado: (2013)

The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer
por: Shetty, Omshree, et al.
Publicado: (2022)

LINC-29. IMPACT OF RELA FUSION ON OUTCOMES OF CHILDHOOD SUPRATENTORIAL EPENDYMOMAS (ST-EPEN)
por: Chinnaswamy, Girish, et al.
Publicado: (2020)

LINC-25. BRAF ABERRATIONS IN PEDIATRIC PILOCYTIC ASTROCYTOMAS (PCAs): PREVALENCE AND IMPACT ON CLINICAL OUTCOME
por: Ramanathan, Subramaniam, et al.
Publicado: (2020)

District level external quality assurance (EQA) of malaria microscopy in Pakistan: pilot implementation and feasibility
por: Khan, Muhammad Amir, et al.
Publicado: (2011)

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
por: Emile, Jean-François, et al.
Publicado: (2013)

Standardization in laboratory medicine: Two years’ experience from category 1 EQA programs in Spain
por: Ricós, Carmen, et al.
Publicado: (2018)

Survey material choices in haematology EQA: a confounding factor in automated counting performance assessment
por: De la Salle, Barbara
Publicado: (2017)

External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany
por: Selb, Regina, et al.
Publicado: (2020)

EQA/PT scheme to improve the equivalence of enzymatic results between mutual recognition laboratories in Beijing
por: Tong, Qing, et al.
Publicado: (2021)

Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation
por: De Paolis, Elisa, et al.
Publicado: (2021)

Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys
por: Keppens, Cleo, et al.
Publicado: (2020)

Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained Settings
por: Kapoor, Akhil, et al.
Publicado: (2022)

Low-Grade Oncocytic Tumor: Report of Two Cases of An Emerging Entity in the Spectrum of Oncocytic Renal Neoplasms
por: Sharma, Divakar, et al.
Publicado: (2022)

Improving accuracy of breast cancer biomarker testing in India
por: Shet, Tanuja
Publicado: (2017)

Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India
por: Kadam Amare, Pratibha S., et al.
Publicado: (2016)

Immune Check Point Inhibitor–Associated Glomerulonephritis
por: Ashour, Tarek, et al.
Publicado: (2018)

Should molecular subtype be recommended as one of the selection criteria for accelerated partial breast irradiation? Preliminary results from an Asian cohort
por: Wadasadawala, Tabassum, et al.
Publicado: (2018)

The WHO AFRO external quality assessment programme (EQAP): Linking laboratory networks through EQA programmes
por: Boeras, Debrah I., et al.
Publicado: (2016)

Comprehensive clinical evaluation of TomoEQA for patient-specific pre-treatment quality assurance in helical tomotherapy
por: Kim, Changhwan, et al.
Publicado: (2022)

Evaluation of a collaborative model for successful implementation of a National CD4 enumeration EQA program in Cameroon
por: Sagnia, Bertrand, et al.
Publicado: (2021)

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers
por: Keppens, Cleo, et al.
Publicado: (2020)

Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect
por: Keppens, Cleo, et al.
Publicado: (2021)

Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Validation of Remote Digital Pathology based diagnostic reporting of Frozen Sections from home
por: Kaushal, Rajiv Kumar, et al.
Publicado: (2023)

Extra-lymphatic filariasis at reconstructive surgery flap site recurrence of head and neck cancer
por: Shetty, Nishitha, et al.
Publicado: (2015)

Ensuring quality in contextualised cancer management guidelines for resource-constraint settings: using a systematic approach
por: Sengar, Manju, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k6fq1cosed2e2rls7ulj37n0ks